Table of contents
July 2002 Vol 2 No 7
In this issue
p479 | doi:10.1038/nrc856
Research Highlights
Oncogenes: A flying start | PDF (70 KB)
p481 | doi:10.1038/nrc854
Metastasis: On the edge | PDF (70 KB)
p482 | doi:10.1038/nrc852
Trial Watch
Cytokine gene therapy | Testing a new receptor tyrosine kinase inhibitor | PDF (70 KB)
p482 | doi:10.1038/nrc859
Prevention: Steering clear of danger | PDF (84 KB)
p483 | doi:10.1038/nrc848
Web Watch
Mad about genomics | PDF (84 KB)
p483 | doi:10.1038/nrc860
Development: Hedgehog proliferation | PDF (183 KB)
p484 | doi:10.1038/nrc846
Epithelial–mesenchymal transition:: A deadly combination | PDF (97 KB)
p484 | doi:10.1038/nrc853
Oncogenesis: The many faces of MYC | PDF (106 KB)
p485 | doi:10.1038/nrc851
Immunotherapy: It takes two to tango | PDF (102 KB)
p486 | doi:10.1038/nrc850
Oncogenes: Fusion power | PDF (102 KB)
p486 | doi:10.1038/nrc858
Telomerase: Immortality and other stories: the dual role of telomerase | PDF (51 KB)
p487 | doi:10.1038/nrc847
News in Brief
Tumour Suppressors | Melanoma | Tumour Targeting | Angiogenesis | PDF (51 KB)
p487 | doi:10.1038/nrc857
Reviews
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Igor Vivanco & Charles L. Sawyers
p489 | doi:10.1038/nrc839
Core-binding factors in haematopoiesis and leukaemia
Nancy A. Speck & D. Gary Gilliland
p502 | doi:10.1038/nrc840
Identification of tumour-associated t-cell epitopes for vaccine development
Stefan Stevanovic
p514 | doi:10.1038/nrc841
Roles of heparan-sulphate glycosaminoglycans in cancer
Ram Sasisekharan, Zachary Shriver, Ganesh Venkataraman & Uma Narayanasami
p521 | doi:10.1038/nrc842
LKB1 — A master tumour suppressor of the small intestine and beyond
Lina I. Yoo, Daniel C. Chung & Junying Yuan
p529 | doi:10.1038/nrc843
Perspectives
Opinion
Chemoprevention: an essential approach to controlling cancer
Michael B. Sporn & Nanjoo Suh
p537 | doi:10.1038/nrc844
Science and society
Cancer after nuclear fallout: lessons from the Chernobyl accident
Dillwyn Williams
p543 | doi:10.1038/nrc845

